← Browse by Condition
Medical Condition
colon neoplasm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06640166 Phase 2
Recruiting
Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Enrollment
25 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT05914389 Phase 2
Recruiting
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
Enrollment
100 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...